About event
The 18th edition of the CAAC-ATVB Symposium is set to take place on May 15th in Chicago, from 11:45 AM to 8:00 PM. This premier event convenes leading experts and researchers in the field of cardiovascular medicine and basic research, aiming to foster a comprehensive understanding of cardiovascular diseases, including atherosclerosis, cerebrovascular damages, aneurysm, and endothelial cell biology.
Participants will have the unique opportunity to engage in insightful discussions, share their latest findings, and collaborate on advancing the frontiers of cardiovascular research. The 18th CAAC-ATVB Symposium promises to be an enriching experience for researchers, clinicians, and academics alike, seeking to enhance their knowledge and contribute to the global effort against cardiovascular diseases.
We look forward to welcoming you to Chicago for an engaging and productive day dedicated to exploring the complexities and challenges of cardiovascular medicine and basic research.
Time: 05/15/2024, 12:00pm -- 8:00pm
Location: 909 S Walcott Ave. Chicago, IL, 60612.
Program
Registration Fees
TIME AND LOCATION
Time:
05/15/2024, 11:45 am -- 8:00pm
Location:
UIC College of Medicine Research Building, Room 1020
909 S Wolcott Ave. Chicago, IL, 60612
Click Here for driving direction from Hilton Chicago to 909 S Wolcott Ave. Chicago, IL. The drive typically takes about 10 minutes in light traffic.
Sponsors
A World Leader in Animal & Cell Line Engineering Services. Biocytogen has been serving customers around the world, both in academia and industry, for over a decade. With our commitment to quality in everything we do, we’ll work closely with you to deliver models and services that meet your precise specifications in a timely manner. We offer world-leading, cutting-edge technology platforms, superior service, a fast timeline, a large collection of animal models for research and a 100 percent satisfaction guarantee.
Click Here to explore their products!
Their proprietary nanoparticle delivery platform is the next generation small molecule and gene delivery technology targeting the vascular endothelium without gene size limitation.
Click Here to explore their products!
Admera Health supports preclinical development and offers research-grade Next-Generation Sequencing and bioinformatic services. We combine expert scientific support, advanced laboratory processes, stringent quality control measures, and proven quality project management to deliver superior service. All projects are handled with exceptional care, operating in a CLIA/CLEP and CAP accredited environment.
Click Here to explore their services!
Abstract Submission Guidelines
AHA Abstract Submission Recommendations: https://www.ahajournals.org/abstract-recommendations
The Abstract Submission Step Is After the Registration.